We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome ( IRIS ) occurring within @ weeks of starting antiretroviral therapy , and to evaluate its association with patient outcome at @ weeks .